Literature DB >> 31189666

Nonclassical Ligand-Independent Regulation of Go Protein by an Orphan Class C G-Protein-Coupled Receptor.

Mariana Hajj1, Teresa De Vita1, Claire Vol1, Charlotte Renassia1, Jean-Charles Bologna1, Isabelle Brabet1, Magali Cazade1, Manuela Pastore1, Jaroslav Blahos1, Gilles Labesse1, Jean-Philippe Pin1, Laurent Prézeau2.   

Abstract

The orphan G-protein-coupled receptor (GPCR) GPR158 is expressed in the brain, where it is involved in the osteocalcin effect on cognitive processes, and at the periphery, where it may contribute to glaucoma and cancers. GPR158 forms a complex with RGS7-β5, leading to the regulation of neighboring GPCR-induced Go protein activity. GPR158 also interacts with αo, although no canonical Go coupling has been reported. GPR158 displays three VCPWE motifs in its C-terminal domain that are putatively involved in G-protein regulation. Here, we addressed the scaffolding function of GPR158 and its VCPWE motifs on Go. We observed that GPR158 interacted with and stabilized the amount of RGS7-β5 through a 50-residue region downstream of its transmembrane domain and upstream of the VCPWE motifs. We show that two VCPWE motifs are involved in αo binding. Using a Gαo-βγ bioluminescence resonance energy transfer (BRET) sensor, we found that GPR158 decreases the BRET signal as observed upon G-protein activation; however, no constitutive activity of GPR158 could be detected through the measurement of various G-protein-mediated downstream responses. We propose that the effect of GPR158 on Go is unlikely due to a canonical activation of Go, but rather to the trapping of Gαo by the VCPWE motifs, possibly leading to its dissociation from βγ Such action of GPR158 is expected to prolong the βγ activity, as also observed with some activators of G-protein signaling. Taken together, our data revealed a complex functional scaffolding or signaling role for GPR158 controlling Go through an original mechanism.
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31189666     DOI: 10.1124/mol.118.113019

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  5 in total

1.  Orphans to the rescue: orphan G-protein coupled receptors as new antidepressant targets.

Authors:  Paul R Albert
Journal:  J Psychiatry Neurosci       Date:  2020-09-01       Impact factor: 6.186

Review 2.  Research Status of the Orphan G Protein Coupled Receptor 158 and Future Perspectives.

Authors:  Xianan Fu; Shoupeng Wei; Tao Wang; Hengxin Fan; Ying Zhang; Clive Da Costa; Sebastian Brandner; Guang Yang; Yihang Pan; Yulong He; Ningning Li
Journal:  Cells       Date:  2022-04-14       Impact factor: 7.666

3.  Structure of the class C orphan GPCR GPR158 in complex with RGS7-Gβ5.

Authors:  Eunyoung Jeong; Yoojoong Kim; Jihong Jeong; Yunje Cho
Journal:  Nat Commun       Date:  2021-11-23       Impact factor: 14.919

4.  Bevacizumab attenuates osteosarcoma angiogenesis by suppressing MIAT encapsulated by serum-derived extracellular vesicles and facilitating miR-613-mediated GPR158 inhibition.

Authors:  Bao-Dong Wang; Xiao-Jun Yu; Ji-Chun Hou; Bo Fu; Hao Zheng; Qi-Kun Liu; Shan-Xi Wang; Zheng-Gang Bi; Yang Cao
Journal:  Cell Death Dis       Date:  2022-03-28       Impact factor: 8.469

Review 5.  Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic Regulation.

Authors:  Md Mominur Rahman; Md Rezaul Islam; Sadia Afsana Mim; Nasrin Sultana; Dinesh Kumar Chellappan; Kamal Dua; Mohammad Amjad Kamal; Rohit Sharma; Talha Bin Emran
Journal:  Oxid Med Cell Longev       Date:  2022-09-21       Impact factor: 7.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.